The Breakthrough T1D San Francisco Gala returns for its 27th year, bringing the T1D community together for "A Magical Night Beneath the Cherry Blossoms" at the iconic San Francisco City Hall. This ...

A breakthrough personalized mRNA cancer vaccine that trains the immune system to target patients' unique tumor mutations is showing promising results. Five-year trial data show the risk of recurrence ...

Iran has vowed to hit back against any American military intervention - Copyright AFP STRINGER Iran has vowed to hit back against any American military intervention ...

US and Iranian officials are due this week to hold their first talks since Iran launched a deadly crackdown on protests, in a meeting likely to be crucial in determining if the US carries out renewed ...

Breakthrough therapy designation targets the post-CDK4/6 setting in PIK3CA-mutant HR+/HER2− advanced disease, where progression is common and therapeutic options remain constrained. Phase 1/2 ...

Tom Petty and the Heartbreakers’ music will “come around here” when Damn the Torpedoes performs Jan. 9 at the Musikfest Café, located in SteelStacks’ ArtsQuest Center, Founders Drive, Bethlehem. The ...

Please provide your email address to receive an email when new articles are posted on . FDA has granted breakthrough designation for litifilimab in patients with cutaneous lupus erythematosus. The ...

Disclosure: Our goal is to feature products and services that we think you'll find interesting and useful. If you purchase them, Entrepreneur may get a small share of the revenue from the sale from ...

While clinical data have improved, Altimmune remains a "cautious Hold" as the stock balances significant regulatory wins against intensifying competitive pressure. 48-week data showed statistically ...

Please provide your email address to receive an email when new articles are posted on . Ianalumab has received the FDA’s breakthrough therapy designation for Sjögren’s disease. Novartis plans to ...

Regulatory submission for ianalumab in Sjögren disease is expected in early 2026, according to Novartis. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...